Literature DB >> 8537288

Evaluation of the E test system versus a microtitre broth method for antifungal susceptibility testing of yeasts against fluconazole and itraconazole.

A L Colombo1, F Barchiesi, D A McGough, A W Fothergill, M G Rinaldi.   

Abstract

The E test strip (AB Biodisk, Solna, Sweden) as an antimicrobial susceptibility testing method is a new and promising tool with broad application in microbiology. This method is less labour intensive than broth dilution methods and may be useful for testing individual clinical isolates. In contrast to several publications comparing E test antibacterial strips with NCCLS reference methods, there is little information about the performance of E test antifungal strips. This study compared fluconazole and itraconazole MICs obtained by E test with a microbroth dilution method performed to NCCLS guidelines. Fluconazole and itraconazole E test results exhibited good correlation with the broth microdilution (82% and 81% agreement within +/- 1 two-fold dilution, respectively). The E test is easy to perform and generates MICs for Candida species in 24 h.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8537288     DOI: 10.1093/jac/36.1.93

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  17 in total

1.  Comparative study of agar diffusion test and the NCCLS macrobroth method for in vitro susceptibility testing of Candida spp.

Authors:  L M Soni; M N Burattini; A C Pignatari; O F Gompertz; A L Colombo
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

2.  Evaluation of Etest method for determining posaconazole MICs for 314 clinical isolates of Candida species.

Authors:  M A Pfaller; S A Messer; K Mills; A Bolmström; R N Jones
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

Review 3.  Azole resistance in Candida.

Authors:  D W Denning; G G Baily; S V Hood
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-04       Impact factor: 3.267

4.  Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents.

Authors:  S P Hawser; H Norris; C J Jessup; M A Ghannoum
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

5.  Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents.

Authors:  R Piccolomini; G Di Bonaventura; G Catamo; F Carbone; M Neri
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

6.  Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds.

Authors:  A Szekely; E M Johnson; D W Warnock
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

Review 7.  Combination treatment of invasive fungal infections.

Authors:  Pranab K Mukherjee; Daniel J Sheehan; Christopher A Hitchcock; Mahmoud A Ghannoum
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

8.  Evaluation of Etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida species.

Authors:  M A Pfaller; S A Messer; K Mills; A Bolmström; R N Jones
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

9.  Evaluation of the susceptibility of pathogenic Candida species to fluconazole. Fluconazole Global Susceptibility Study Group.

Authors:  J Bille; M P Glauser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-12       Impact factor: 3.267

10.  Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media.

Authors:  M A Pfaller; S A Messer; A Karlsson; A Bolmström
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.